PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
Recent studies have shown that PPP1R14B was highly expressed in tumor tissues and patients with high expression of PPP1R14B had poor survival rates. However, the function and mechanisms of PPP1R14B in tumor progression remain ill defined. There was also lack of pan-cancer evidence for the relationsh...
Guardado en:
Autores principales: | Mingxia Deng, Long Peng, Jiamin Li, Xiong Liu, Xichun Xia, Guangqiang Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f0e57153bd148759e912347e8ef8995 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1)
por: Shuang Gao, et al.
Publicado: (2021) -
Pan-Cancer Analysis of the Solute Carrier Family 39 Genes in Relation to Oncogenic, Immune Infiltrating, and Therapeutic Targets
por: Yi-Yuan Qu, et al.
Publicado: (2021) -
Prognostic and immunological value of LTB4R in pan-cancer
por: Sidan Long, et al.
Publicado: (2021) -
MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Xiaoyu Zhang, et al.
Publicado: (2021) -
Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort
por: Yi Liu, et al.
Publicado: (2021)